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Abstract
Background: HIV-related stigma and discrimination (S&D) are recognized as key impediments to controlling the
HIV epidemic. S&D are particularly detrimental within health care settings because people who are at risk of HIV
and people living with HIV (PLHIV) must seek services from health care facilities. Standardized tools and monitoring
systems are needed to inform S&D reduction efforts, measure progress, and monitor trends. This article describes
the processes followed to adapt and refine a standardized global health facility staff S&D questionnaire for the context
of Thailand and develop a similar questionnaire measuring health facility stigma experienced by PLHIV. Both
questionnaires are currently being used for the routine monitoring of HIV-related S&D in the Thai healthcare system.
Methods: The questionnaires were adapted through a series of consultative meetings, pre-testing, and revision. The
revised questionnaires then underwent field testing, and the data and field experiences were analyzed.
Results: Two brief questionnaires were finalized and are now being used by the Department of Disease Control to
collect national routine data for monitoring health facility S&D: 1) a health facility staff questionnaire that collects data
on key drivers of S&D in health facilities (i.e., fear of HIV infection, attitudes toward PLHIV and key populations, and
health facility policy and environment) and observed enacted stigma and 2) a brief PLHIV questionnaire that captures
data on experienced discriminatory practices at health care facilities.
Conclusions: This effort provides an example of how a country can adapt global S&D measurement tools to a local
context for use in national routine monitoring. Such data helps to strengthen the national response to HIV through the
provision of evidence to shape S&D-reduction programming.
Background
Thailand is globally recognized for its achievements in
controlling the HIV epidemic and establishing quality
care and treatment programs for people living with HIV
(PLHIV) [1]. However, despite continued HIV preven-
tion efforts and the provision of free and universal access
to antiretroviral treatment (ART), AIDS-attributed
deaths have remained steady, and the average CD4 count
at ART initiation remains low [2]. Additionally, warning
signs suggest that Thailand may face another wave of
the HIV epidemic; indeed, new infections among key
populations (KPs), especially men who have sex with
men, are rising [3].
Globally, the detrimental effect of stigma and discrim-
ination (S&D) on HIV prevention and, ultimately, each
step in the HIV care continuum—testing, linkage to care,
retention in care, adherence, and viral suppression—is
increasingly well documented [4–10]. Although S&D
occur at each socio-ecological level of society, HIV-
related S&D in health facilities is particularly harmful to
health and wellbeing and has been documented in mul-
tiple studies worldwide [11–15]. Additionally, growing
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evidence indicates that S&D are key factors hampering
an effective HIV response in Thailand by undermining
HIV testing, treatment, and retention [16]. The 2009–
2010 “Index of Stigma and Discrimination against People
living with HIV/AIDS in Thailand” study confirmed the
prevalence of many forms of S&D [17], and other studies
in Thailand have also demonstrated the negative influ-
ence of S&D on prevention and treatment. A study
among men who have sex with men and transgender
persons found that HIV-related S&D were inversely
associated with the intention to test for HIV and rectal
microbicide acceptability [18], and a survey of PLHIV
linked HIV-related stigma with low adherence to ART
[19]. Furthermore, a qualitative study found that per-
ceived stigma, shame, and fear of rejection were key
barriers to HIV disclosure among PLHIV [20]. Stigma
toward PLHIV exists throughout Thai society, as
reflected by the results of the recent National Health
Examination Survey of Thai households: 51% of re-
spondents reported that they would not buy fresh vege-
tables from a shopkeeper or vendor if they knew that
the seller had HIV, and 22% thought that children living
with HIV should not attend school with HIV-negative
children [21].
Given this situation, the 2014–2016 Thailand National
AIDS strategy set S&D reduction as a key goal and
established a target of halving the prevalence of discrim-
ination against PLHIV and other KPs by the end of 2016
relative to the level in 2012 [22]. As part of achieving
this target, the National AIDS strategy also recognizes
that routine S&D data collection is important to be able
to track progress and design effective S&D-reduction
programs. In response, the National AIDS Management
Center, which is the government body under the Depart-
ment of Disease Control in the Ministry of Public Health
tasked with coordinating national data collection for
HIV response, coordinated a study team of academics
from the International Health Policy Program and
Chiang Mai University and the public health staff from
the two study sites—Chiang Mai Provincial Health
Office and Bangkok Metropolitan Administration—to
adapt and pilot a global standardized tool to measure
health facility S&D to the Thai context [23].
The global tool [24] was created through an effort to
create a brief enough standardized questionnaire that
would be feasible to implement in programmatic appli-
cations (e.g. routine monitoring and/or evaluation of
country-level or health facility-level activities), but still
capture the essential domains of stigma within health
facilities. This tool was developed through a multi-step
process. Global stigma measurement experts reviewed
existing validated tools and designed a combined short-
ened questionnaire to cover the key HIV stigma do-
mains shown to be important for stigma-reduction
programming in health facilities. This questionnaire
was then field-tested in six diverse country settings.
Resulting data was analyzed across sites using explora-
tory factor analysis, principle component analysis and
combined with qualitative data from the field adminis-
tration experience. Principal investigators across sites
met in person to review all evidence and come to con-
sensus on what items to retain and which ones to
remove. The final global tool not only measures mani-
festations of stigma but also the following key action-
able drivers of stigma: fear of HIV infection, attitudes
toward PLHIV and KPs, and health facility policies and
environment [24]. These stigma drivers are modifiable
and can be addressed through targeted stigma-
reduction interventions. The global measurement tool
was also designed to capture the perspectives of all
cadres of healthcare facility staff from clinical care pro-
viders to non-medical professionals.
This paper describes the process of adapting the stan-
dardized global S&D health facility questionnaire for the
Thai context and developing a new tool for measuring
the experience of health facility-related S&D among
PLHIV in Thailand.
Methods
Questionnaire adaptation and development process
The primary purpose of this exercise was to develop
brief standardized questionnaires that capture key HIV-
related S&D domains in Thai healthcare facility settings
for use in a national monitoring system. Figure 1 depicts
the five key steps of the process used; each step is de-
scribed in more detail below.
Consultative meeting to adapt and draft the
questionnaires
To kick-off the process, a three-day consultative meet-
ing was convened to adapt the two questionnaires
(health facility staff and PLHIV). Participants included
multiple stakeholders from civil society (PLHIV, KPs,
and non-governmental organizations), the donors (the
International Labor Organization] and United States
Agency for International Development), and other
international organizations (the Joint United Nations
Programme on HIV/AIDS, United Nations Develop-
ment Programme, United Nations Population Fund,
and United Nations Children’s Fund). Using the global
health facility survey questionnaire [23] as the base,
participants added and adapted content until consen-
sus that the questionnaire covered all necessary topics
and adequately suited the Thai context was reached.
The PLHIV questionnaire was constructed in parallel
by adopting questions designed to capture stigma in
health facilities from the 2009 Thai PLHIV Stigma
Index Survey [25].
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The first draft of the Thai health facility staff question-
naire contained 59 questions and six sections: back-
ground information, infection control, health facility
environment, health facility policies, attitudes toward
PLHIV and KPs, and a special module on stigma toward
pregnant women living with HIV for staff who work with
pregnant women. The questionnaire was significantly
longer than the global questionnaire because questions
were added to capture additional dimensions that the
group felt might be key in the Thai context. For ex-
ample, specific questions pertaining to KPs who are par-
ticularly vulnerable to HIV and S&D in the Thai setting
were included. Because participant literacy was not a
concern, it was decided that the health facility staff ques-
tionnaire would be self-administered to reduce response
bias.
The first draft of the PLHIV questionnaire contained 31
questions and five sections: demographic characteristics
and history of HIV infection and treatment, experience of
receiving health services in the context of discrimination,
internalized stigma, disclosure of HIV status, and discrim-
ination related to reproductive health. A sixth section con-
tained questions related to pregnancy that were asked
only of women living with HIV. Questions about discrim-
inatory practices that may be specific to living with HIV in
Thailand addressed topics such as being asked to place a
hospital robe in an area or basket specifically designated
for HIV or being advised to avoid becoming pregnant
(e.g., being told “Don’t sin anymore”).
The meeting participants also agreed that capturing
information on sexual orientation, gender identity, and
other KP status (i.e., sex workers, migrants, and persons
who inject drugs) would be important. Given the sensi-
tive nature of this information, this question was asked
at the end of the questionnaire. Respondents were given
the option to respond directly to the interviewer or to
read and complete the question themselves. The PLHIV
questionnaire was designed to be administered through
face-to-face interviews because the research team antici-
pated some challenges with literacy amongst the poten-
tial respondents.
Questionnaire pre-testing
The first-draft questionnaires were pre-tested in two
government hospitals in the provinces of Nonthaburi
and Lampoon, which are fairly similar to the provinces
in which the future field testing would occur in terms of
their language, culture, and environment. The health fa-
cility staff questionnaire was piloted among purposive
samples of 10 participants in each hospital: five health
staff who were directly involved in caring for PLHIV
(i.e., a physician, counselor nurse, ART clinic nurse, tu-
berculosis clinic nurse, and sexually transmitted infec-
tion clinic nurse) and five heath staff whose work did
not directly involve caring for PLHIV. These participants
then participated in two focus group discussions (one at
each hospital) to provide feedback on the questionnaire.
The first-draft PLHIV questionnaire was piloted with six
PLHIV at each hospital. After the interviews, the respon-
dents were asked to provide feedback on the content
and language of the questionnaires individually.
Study team meeting to consider the pre-test results and
respondent feedback
The study team revised the questionnaires to address
the issues raised by the pre-test. Most health staff re-
spondents found the questionnaire to be understandable
but recommended that the background and purpose of
the survey be explained more clearly at the outset. They
also suggested changes to the wording and content of
some questions. For example, they noted that questions
on concerns relating to touching the clothing or bedding
Fig. 1 Process and timeline for questionnaire development
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of PLHIV needed to specify that the answer should be
limited to the scope of work in the hospital and should
not include behavior at home or outside the hospital.
They also found the KP section quite lengthy and repeti-
tive and indicated that it be shortened or re-formatted
into a table. PLHIV respondents identified several con-
fusingly worded questions and suggested alternative
language. For example, they noted that questions asking
about experiences accessing health services needed to
clarify that “using health services” meant “accessing
care from ‘any health facility,’” not just the one they
were being interviewed at. Overall, revisions were min-
imal to both questionnaires and mainly related to the
format, language, and flow of the questions. Tables 3
and 4 provide details about the second drafts of both
questionnaires that were then field tested.
Questionnaire field testing
The second-draft questionnaires were field tested in se-
lected hospitals in Bangkok and Chiang Mai provinces.
Bangkok was chosen to represent an urban setting,
whereas Chiang Mai represents a rural setting, with
most field-testing sites being community hospitals lo-
cated far from Chiang Mai city.
Sample size
The target sample size was 350 health facility staff and
PLHIV in each site, with 300 PLHIV respondents re-
cruited through hospitals and 50 from PLHIV networks
(Tables 1 and 2).
Sampling strategy
Only facilities with ART clinics were invited to partici-
pate. In Bangkok, this included all government hospitals
under the Bangkok Metropolitan Administration and
Department of Medical Services and purposively se-
lected private hospitals. In Chiang Mai, this was all com-
munity hospitals under the Ministry of Public Health,
which were then stratified by number of PLHIV clients
as follows: small (<300; 11 hospitals), medium (300–400;
seven hospitals), and large (>400; six hospitals). Five hos-
pitals from each stratum were purposively selected.
Three private hospitals in Chiang Mai were also purpos-
ively approached. In total, 32 hospitals in both locations
agreed to participate: 26 government facilities and six
private facilities.
Eligible medical and non-medical staff were catego-
rized into two groups: Group 1 worked in wards where
PLHIV received care (e.g., HIV counseling, ART, Tuber-
culosis, Sexually Transmitted Infection, and antenatal
care clinics), and Group 2 worked in other hospital
units. In Bangkok and Chiang Mai, all Group 1 staff
were approached for an interview (5–10 people per hos-
pital). For Group 2, the goal was 15–20 staff per hospital
in Chiang Mai and 20–25 staff per hospital in Bangkok.
Staff without direct patient contact, such as administra-
tive staff, accountants, bookkeepers, and engineering/
maintenance staff, were excluded.
Because the hospitals in Chiang Mai were small, the
research team was able to obtain a list of all staff names
organized by profession and department from which to
draw the sample. A systematic random sampling tech-
nique was used to choose the Group 2 staff from each
hospital until the desired sample size was achieved. In
Bangkok, complete lists of all staff working in the hospi-
tals were unavailable because of the complex structure
of the hospitals’ administration systems. Therefore, the
research team approached major departments within
each hospital to determine the total numbers of depart-
ment staff by profession. These numbers were then used
to determine the number of staff by profession to be
interviewed in each department. The data collector then
approached the departments with the number and list of
staff types to be collected and invited all staff in the tar-
geted categories who were working that day to complete
the questionnaire until the target number for each staff
type in each department was reached.
PLHIV respondents were recruited at a subset of con-
veniently selected health facilities: six government hos-
pitals and three private hospitals in Bangkok and six
government hospitals (two hospitals representing each
size category) and two private hospitals in Chiang Mai.
To achieve the target samples of PLHIV from the
clinics, 30–45 PLHIV were interviewed at each hospital
in both locations. Potential patient participants were
approached privately by ART clinic staff during their
scheduled appointments, provided a brief overview of
the research study, and then invited to participate in
the study. Interested participants were introduced to an
interviewer in a private room. A consecutive sampling
technique was used until the target sample size was
achieved. A convenience sample of 10–15 PLHIV




no. of hospitals no. of participants no. of hospitals no. of participants
Government 11 289 15 304
Private 3 90 3 55
Total 14 379 18 359
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respondents were recruited from six PLHIV networks
in Bangkok and three PLHIV networks in Chiang Mai.
Eligible PLHIV participants were 18 years or older and
were either currently accessing care from the selected
facility or referred by associated networks.
Data collection process
The study received ethical approval from the Institute
for the Development of Human Research Protections,
Bangkok Metropolitan Administration three individual
hospitals in Bangkok, and Chiang Mai provincial health
office.
Typically, the study team gathered potential health
staff respondents in a conference room and shared the
study objectives, participation benefits and risks, and
time required to participate and stressed that partici-
pation was voluntary and that responses would be
confidential. Interested participants provided signed
inform consent before filling out the questionnaire.
Each respondent received a small gift (worth US$6) to
compensate them for their time.
PLHIV at health facilities who sought out the inter-
viewer after learning about the study from a health pro-
vider were informed about the purpose of the study and
the risks and benefits of participation and were assured
that participation was entirely voluntary, that the inter-
view could be stopped at any time they wished, that their
answers were confidential, and that participation would
not affect future services received at the facility. If the
participant still wanted to participate and provided writ-
ten informed consent, a face-to-face interview was con-
ducted in a private room. For PLHIV recruited through
a network, the network coordinators were responsible
for providing basic information about the study and in-
viting members to participate. For those who chose to
participate, a process similar to that described above was
followed, including the collection of signed informed
consent. Trained interviewers conducted all interviews
and were neither employed by any of the participating
health facilities nor members of any of the partnering
PLHIV networks. The respondents in Bangkok received
500 baht (~US$14), and the respondents in Chiang Mai
received 300 Baht (~US$9) to compensate them for their
time and traveling costs.
Data management and initial analysis
Data from the field test were entered into Excel, trans-
ferred into STATA (version 13), and cleaned. Preliminary
data analysis was conducted looking at basic frequencies,
cross tabs, and factor analysis in preparation for a full-
team data analysis workshop.
Data analysis workshop
A five-day data analysis workshop was held to consider
the field-implementation experience and conduct joint
data analysis. Participants included the study team mem-
bers and an international expert who was involved in the
development of the global tool. Key feedback from the
field implementation was that both questionnaires were
too long. Additionally, the questionnaires needed to be
shortened to be feasible for used by the Ministry of Pub-
lic Health to collect routine S&D monitoring data. Thus,
the overarching goal of the analysis was to reduce the
questionnaires without sacrificing their ability to com-
prehensively measure key drivers and manifestations of
stigma.
The field-testing implementation experience was used
to evaluate the questionnaire items in terms of the fol-
lowing criteria: “comprehension” (Did the respondents
easily understand the question? Did they have to ask
for clarification? Did interviewers have to rephrase
questions to make them more understandable? If so,
was translation the root of the issue or was the ques-
tion asked in a way that did not convey the meaning of
what we were trying to capture?), “sensitivity” (Did the
question make the respondent uncomfortable? Did this
lead to a refusal to answer?), and “flow and length of
the questionnaire” (Were there any issues with skip pat-
terns? Was it difficult for respondents to follow the
flow of the questionnaire? Did respondents complain
about the length of the questionnaire?).
“Item performance” was examined by assessing
each individual item and sets of items grouped to-
gether based on the following criteria: variability,
missing or misplaced responses, relevance, and cri-
terion validity. The items were then further assessed
using count variables, cross-tabulations, and univer-
sality. The details of the resulting questionnaires are
described below.
Table 2 Number of PLHIV respondents, by study site and location
Hospital type Bangkok Chiang Mai
no. of locations no. of locations no. of locations no. of locations
Government hospital 6 210 6 230
Private hospital 3 105 2 69
PLHIV network 6 50 3 50
Total 15 365 11 349
Srithanaviboonchai et al. BMC Public Health  (2017) 17:245 Page 5 of 11
Results
Final brief health staff questionnaire
[see Additional file 1 for details]
This questionnaire consists of 14 questions containing
26 items. Although it is significantly shorter than the
field-test version, the final questionnaire still captures
every domain included in prior versions, except for the
module on pregnant women living with HIV. This sec-
tion was deleted because it was not relevant for most of
the sampled health staff, however, an attitudinal question
regarding childbearing among PLHIV was retained as
part of the attitudes section. Table 3 presents the num-
ber of questions/items in each section of the global
questionnaire, the Thai field-test questionnaire, and the
final Thai brief questionnaire. Note, the differences be-
tween the global questionnaire and the final Thai brief
questionnaire were minimal (Table 3).
Background information
The number of background information questions was
reduced from eight to three in the final brief question-
naire; the retained questions included current position
and two questions assessing whether respondents have
received specific training in S&D reduction. Questions
on age, sex, years of work, and number of HIV patients
served were removed given a programmatic decision to
target all health facility staff with S&D-reduction
Table 3 Results of health facility staff questionnaire development
















Background information Demographics 2 2 3 3 - -
Jobs related 4 4 4 9 1 1
Training on S&D 1 1 1 8 2 3
Total 7 7 8 20 3 4
Key drivers
of stigma
Infection control Fear of HIV infection 1 4 1 4 1 3
Avoidance Behavior driven
by fear
1 4 1 3 1 2
Supplies - - 1 1 - -
Total 2 8 3 8 2 5
Health facility
policies
HIV testing 1 1 1 1 1 1
Punishment for discrimination 1 1 1 1 1 1
Supplies and standard procedures 1 2 1 2 1 1
Written guideline on S&D 1 1 1 1 1 1
Not allow PLHIV to be staff - - 1 2 - -
Total 4 5 5 7 4 4
Opinions about
PLHIV and KP
PLHIV 1 5 1 4 1 4
Women living with HIV 1 1 2 2 1 1
KP 3 12 34 59 1 5
Total 5 18 37 65 3 10
Manifestations
of stigma
Enacted stigma Screening question 1 1 1 1 - -
Observed stigma 1 3 1 3 1 2
Attitude towards PLHIV staff 1 3 2 2 1 1
Secondary stigma 1 1 1 3 - -
Total 4 8 5 9 2 3
Module for stigma towards
pregnant women living
with HIV
Fear of HIV infection 1 1 1 1 - -
Observed stigma 1 5 1 5 - -
Attitudes towards HIV positive
pregnant women
1 4 1 4 - -
Total 3 10 3 10 - -
Total 25 56 61 119 14 26
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activities; as a result, these questions were, therefore,
deemed unnecessary.
Key drivers of stigma
Infection control
The number of questions asking about infection control
was reduced from three to two in the final brief ques-
tionnaire. The first retained question asks about the level
of fear of HIV transmission while conducting routine ac-
tivities in the health setting and has three items: touch-
ing the personal belongings of, dressing the wounds of,
and drawing blood from PLHIV. These three items were
kept because they covered both a range of typical actions
that different health staff might engage in and a range of
HIV transmission risks. The second retained questioned
assess self-reported stigmatizing avoidance behavior
driven by transmission fear; this question included two
items: wearing double gloves and typically using special
precautions for infection control with PLHIV only.
Health facility policy
The number of questions asking about health facility
policy was reduced from five to four in the final brief
questionnaire. Retained questions probed respondents’
views regarding HIV testing with patients’ consent,
repercussions for discriminating against PLHIV, the
adequacy of supplies to protect health staff from HIV in-
fection, and the existence of written guidelines to protect
PLHIV patients from discrimination.
Opinions about PLHIV and Attitudes and Behaviors
towards KPs
The number of questions asking about attitudes to-
ward PLHIV and KPs was reduced from 37 to only two
in the final brief questionnaire. The retained questions
were as follows: 1) the field-tested question asking
about negative attitudes toward PLHIV and its four
items and 2) a question about whether women living
with HIV should be allowed to have children. Numer-
ous attitudinal questions relating to KPs were also
considered. Given the length constraints (and the fact
that each KP question essentially adds multiple ques-
tions, one for each KP of interest), the team examined
the response to each question and concluded that the
most important question to keep was one relating to
observed stigma (see the section on enacted stigma
below). Indeed, this question returned the highest pro-
portion of responses among the KP-specific questions,
and the workshop participants felt that this was the




The number of questions asking about enacted stigma
toward PLHIV was reduced from five to two in the final
brief questionnaire. One question addressed observed
stigma in the past 12 months with two items: unwilling-
ness to care for and the provision of a reduced quality
of care to PLHIV. Observed stigma, rather than the
respondents’ behaviors themselves, was asked about be-
cause most health staff know that such acts of discrim-
ination are not socially desirable and, thus, would likely
under report. A question assessing the level of comfort
with working with co-workers who are living with HIV
was also retained. The questions on secondary stigma
associated with providing care to PLHIV were removed
because of lack of variation. Finally, a question asking
about observing (in the past 12 months) other health
facility staff being unwilling to care for a patient in the
past 12 months who was or was thought to be from
one of five KP groups (men who have sex with men,
transgender women, sex workers, drug users, and mi-
grants) was included in table format.
The final brief PLHIV questionnaire
[see Additional file 2 for details]
The final brief PLHIV questionnaire includes 17 ques-
tions with 33 items covering five domains (Table 4).
Background information
The number of background information questions was
reduced from 10 to six in the final brief questionnaire.
The first five questions on age, type of health insurance,
duration of using health care services, length of knowing
HIV status, and status of ART were placed at the start of
the questionnaire. Because of its sensitivity, the question
on gender identity (i.e., male, female, or transgender),
sexual orientation (i.e., gay, lesbian, or bisexual), and
other KP status (i.e., people who inject drugs, sex
workers, or migrants) was included at the end of the
questionnaire. Respondents could opt to answer this
question on their own and seal the questionnaire or have
the interviewer check the answers for them. This strat-
egy worked well, with many respondents opting to an-
swer this question on their own.
Health-related stigma
This section included questions about anticipated, ex-
perienced, and internalized stigma related to the
utilization of health services. The number of questions
was reduced from five to four in the final brief ques-
tionnaire. The first question asked whether anticipated
stigma hampered access to care and treatment among
PLHIV: “In the last 12 months, have you avoided going
to or delayed going to a health care facility near your
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home for HIV-specific services or for other general
health issues/problems (not specific to HIV illness)?” A
similar question—about ANC and prevention of
mother-to-child HIV transmission services—was asked
of women who had ever been pregnant while living with
HIV. These questions have three response categories that
the interviewers can choose from as reasons for the re-
spondent’s avoiding/delaying accessing services: 1) stigma-
related reasons (e.g., fear of disclosure of HIV status), 2)
stigma-related reasons regarding quality of care (e.g., an-
ticipated unfriendly services), and 3) non-stigma-related
reasons (e.g., no transportation or no health insurance).
The field-tested ‘experience of stigma among pregnant
women’ section was removed to avoid repetition.
Eleven out of 19 field-tested items measuring experi-
enced stigma at health care facilities were retained: de-
nial of care, treatment given on a conditional basis, delay
of care, patient’s medical record visibly marked as HIV
positive, talked with rudely (e.g., scolded or blamed),
poor quality of care, service providers’ avoidance of
touching them, and discrimination in an in-patient ward
(e.g., bed marked as being HIV positive).
This section also included one self-stigma question
with two sub-items that asked about feeling ashamed or
guilty for being HIV positive.
Disclosure and confidentiality
Three questions regarding disclosure and confidential-
ity of HIV status were retained in the final PLHIV
questionnaire: 1) involuntary disclosure of HIV status
by health facility staff to other people without the pa-
tient’s consent, 2) respondents’ level of confidence that
health providers would keep their HIV status confi-
dential, and 3) non-adherence to ART because of a
fear that taking the medication would reveal HIV sta-
tus to others. The question asking how health care
providers knew the respondent was living with HIV
was dropped because the disclosure of HIV status to
health care providers is generally unavoidable and ac-
ceptable in the Thai context.
Stigma in relation to reproductive health
The number of questions asked of both male and female
respondents about reproductive health was reduced
from six to four in the final brief questionnaire. The four
retained questions included were the following: ever be-
ing advised not to have sex, not to have children, or to
terminate a pregnancy, or to have been provided ART
under the condition of taking contraception or undergo-
ing sterilization.
Table 4 Results of PLHIV questionnaire development
Section Issues questioned Field-test questionnaire Final questionnaire
No. of question No. of item No. of question No. of item
Background Demographics 5 6 2 2
Usage of health services 3 5 3 4
Gender and KP 2 2 1 1
Total 10 13 6 7
Health related stigma Anticipated stigma 3 5 2 6
Experienced stigma 1 21 1 11
Internalized stigma 1 9 1 2
Total 5 35 4 19
Disclosure and confidentiality Disclosure of HIV status 2 2 1 1
Confidentiality 1 1 2 2
Total 3 3 3 3
S&D in relation to reproductive health Sex and marriage 2 2 1 1
Having children 4 4 3 3
Total 6 6 4 4
Experience of stigma among
pregnant women
Screening question 1 3 - -
Termination of pregnancy 1 2 - -
Prevention of mother to child HIV transmission 1 2 - -
Disclosure of HIV status 2 2 - -
Total 5 9 - -
Total 29 66 17 33
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Discussions
The process Thailand used to systematically adapt a glo-
bal standardized health facility staff S&D questionnaire
and develop a PLHIV questionnaire for the routine
monitoring of HIV-related S&D provides a roadmap and
lessons learned for other countries seeking to measure
S&D. The adaptation process in Thailand demonstrates
that the standardized global measurement instrument
for health facility staff, which was originally tested in six
countries with different HIV epidemic, health system,
language and cultural contexts, also worked well for
Thailand. Most of the global questionnaire was retained
in the final brief Thai version, indicating that other
countries may be able to adapt the global questionnaire
with minimal effort to their local context and monitor-
ing needs.
This process also demonstrated the importance of col-
lecting the patient perspective alongside that of health
facility staff. Having both perspectives allows for the tri-
angulation of data by comparing PLHIV reporting expe-
rienced stigma in health facilities with health staff
reporting observed stigma. Having data from both per-
spectives can in and of itself provide an important
stigma-reduction intervention opportunity. When staff
and clients share data from their differing perspectives,
this can provide ‘neutral’ evidence to initiate discussions
and dialogue on how to change the situation described
by the data.
Several key factors contributed to the success of this
adaptation process. First was the inclusion of all key
stakeholders. Bringing together diverse perspectives and
experiences from the outset helped ensure that no sig-
nificant questions were left out and that the final prod-
uct would be widely accepted and utilized. Second, a
strong partnership between the Ministry of Public
Health, which is the authoritative body responsible for
all HIV-related activities, and researchers with available
time and expertise contributed to the success achieved
here. The National AID Management Committee, which
is responsible for the national HIV monitoring system,
helped coordinate the study greatly facilitating collabor-
ation with the selected health facilities. Lastly, the study
was supported through joint funding by the Inter-
national Labor Organization, United States Agency for
International Development, and the U.S. President’s
Emergency Plan for AIDS Relief, which allowed this
study to receive strong technical assistance from inter-
national experts.
The study benefitted in many ways from the input of
experts who took part in the development of the global
tools. These experts helped ensure that all key concepts
and theories were understood by the local teams; that
technical terms and their meanings would be consistent
with those used in the global tools; that the processes
used to develop, test, and refine the tools would be sci-
entifically rigorous; and that all necessary S&D domains
would be retained in the final brief questionnaires.
In addition to the questionnaires, the study team also
developed a survey guidelines and procedures manual
(available in Thai and English) [26]. It provides guidance
on sample size calculation techniques, sampling proce-
dures, informed consent procedures, data collection,
data entry, and quality assurance. This by-product has
been used by provincial public health staff as implemen-
tation guidelines and as training material during the es-
tablishment of a national S&D monitoring system.
In 2015, the national network of the surveillance sys-
tem used to monitor HIV-related S&D in Thai health
care settings was established under the leadership of the
National AIDS Management Committee with technical
support from this study’s research team. The network
comprises sites in seven provinces, including the two
provinces where field-testing was conducted. The first
round of routine data collection was successfully imple-
mented by the provincial teams using the tools and
methodology developed in this study. A data analysis
and result interpretation workshop involving the provin-
cial S&D data collection teams was held at the provincial
health office and teams were encouraged to bring the
data back to their provinces to use in designing S&D-
reduction interventions. At the central level, the results
are being used as baseline national estimates and as in-
puts for designing a national health facility intervention
approach, which is currently being pilot tested in gov-
ernment hospitals in four selected provinces. In 2015–
2016, twelve provinces outside the nationally supported
surveillance network used their own provincial resources
to collect S&D data, and at least 7 more provinces will
do so in 2017. These actions demonstrate the growing
commitment to understanding and addressing S&D
across the country.
Data and interventions beyond the health care settings
will also be needed to fully and strategically address HIV-
related S&D. For Thailand, other activities regarding HIV-
related S&D are also planned. To support these activities,
questions on attitudes toward PLHIV were included in
the recently conducted 5th national health examination
survey [21]. This large multi-stage probability sampling
survey of the general adult public included the ques-
tions necessary to report on the Global AIDS Response
Progress Reporting global indicator for discriminatory
attitudes toward PLHIV [27]. Using processes similar to
those used in this study, another set of brief questions
was also developed to monitor the S&D experienced by
KPs. The national HIV data committee recently en-
dorsed the incorporation of these questions into the na-
tion’s next round of the Integrated Biological and
Behavioral Surveillance survey.
Srithanaviboonchai et al. BMC Public Health  (2017) 17:245 Page 9 of 11
There are some limitations inherent to this study and
adaptation process. The tools were tested at only two
sites, and thus, the data gathered might not represent
the opinions of all health staff and PLHIV in Thailand.
The Thai tool was modeled after the standardized global
tool that, while evidence-based and programmatically
useful, had to allow for variability in sampling method-
ology and administration. Further statistical analysis to
compare the global S&D measurement tool to the Thai
measurement tool would have been valuable and could
possibly have strengthened the adaptation and refine-
ment process. However, as the Thai questionnaire
included only minimal changes from the global ques-
tionnaire, formal re-validation was deemed unnecessary.
In future adaptation efforts, cross-context validation is
advisable should more extensive adaptations be under-
taken. Despite these shortcomings, the Thai tool covers
each of the stigma domains deemed pertinent to
stigma-reduction in healthcare facilities, is practical and
feasible to implement and is being used to support
stigma measurement, reduction, and monitoring for the
Thai national program to reduce S&D. That twelve
provinces in Thailand chose to use their own provincial
funds to collect S&D data using these tools indicates
the usefulness, appropriateness and feasibility of imple-
mentation of these tools. Additionally, the lengthy and
elaborate process that Thailand went through, while
yielding quality results, may not be replicable by
other countries because of time and resource con-
straints. However, in sharing the Thai experience, we
hope to provide a model process that can be a flex-
ible and adaptable guide for others and to share an
experience demonstrating that the global tool can
likely be adapted via a much shorter process than
that used by Thailand.
The overall process establishes that S&D can be mea-
sured at scale as part of a national HIV response and
provide essential data for developing evidence-based
stigma-reduction programming for health facilities. The
transferability of the measurement tools and approach is
currently being demonstrated by the implementation of
a similar approach with a much briefer adaptation
process in Lao People’s Democratic Republic with tech-
nical assistance from this study’s research team. Both
processes demonstrate how a global tool for measuring
the HIV-related S&D in health care settings can be
readily adapted and used for routine monitoring. Given
the growing recognition of the severity of S&D in
healthcare facilities, global targets have been set to
prioritize the provision of stigma-free health services
[28, 29]. The tools and processes described here offer
an example of how to monitor progress toward meeting
those targets and collect data to inform interventions
to achieve those targets.
Conclusions
Measuring S&D for routine national monitoring and
stigma-reduction intervention design and evaluation is
feasible, as demonstrated by the work performed in
Thailand. The experience of adapting a standardized glo-
bal tool for measuring health facility staff S&D in
Thailand provides a roadmap for other countries.
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